777 related articles for article (PubMed ID: 26297437)
1. Wnt/β-Catenin Signaling Activation beyond Robust Nuclear β-Catenin Accumulation in Nondysplastic Barrett's Esophagus: Regulation via Dickkopf-1.
Lyros O; Rafiee P; Nie L; Medda R; Jovanovic N; Otterson MF; Behmaram B; Gockel I; Mackinnon A; Shaker R
Neoplasia; 2015 Jul; 17(7):598-611. PubMed ID: 26297437
[TBL] [Abstract][Full Text] [Related]
2. In-depth characterization of the Wnt-signaling/β-catenin pathway in an in vitro model of Barrett's sequence.
Götzel K; Chemnitzer O; Maurer L; Dietrich A; Eichfeld U; Lyros O; Moulla Y; Niebisch S; Mehdorn M; Jansen-Winkeln B; Vieth M; Hoffmeister A; Gockel I; Thieme R
BMC Gastroenterol; 2019 Mar; 19(1):38. PubMed ID: 30841855
[TBL] [Abstract][Full Text] [Related]
3. Dickkopf-1, the Wnt antagonist, is induced by acidic pH and mediates epithelial cellular senescence in human reflux esophagitis.
Lyros O; Rafiee P; Nie L; Medda R; Jovanovic N; Schmidt J; Mackinnon A; Venu N; Shaker R
Am J Physiol Gastrointest Liver Physiol; 2014 Apr; 306(7):G557-74. PubMed ID: 24481601
[TBL] [Abstract][Full Text] [Related]
4. The novel target of esophageal squamous cell carcinoma: lncRNA GASL1 regulates cell migration, invasion and cell cycle stagnation by inactivating the Wnt3a/β-catenin signaling.
Ren Y; Guo T; Xu J; Liu Y; Huang J
Pathol Res Pract; 2021 Jan; 217():153289. PubMed ID: 33248356
[TBL] [Abstract][Full Text] [Related]
5. Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action.
Tselepis C; Perry I; Dawson C; Hardy R; Darnton SJ; McConkey C; Stuart RC; Wright N; Harrison R; Jankowski JA
Oncogene; 2002 Sep; 21(39):6071-81. PubMed ID: 12203119
[TBL] [Abstract][Full Text] [Related]
6. Wnt/β-catenin signaling via Axin2 is required for myogenesis and, together with YAP/Taz and Tead1, active in IIa/IIx muscle fibers.
Huraskin D; Eiber N; Reichel M; Zidek LM; Kravic B; Bernkopf D; von Maltzahn J; Behrens J; Hashemolhosseini S
Development; 2016 Sep; 143(17):3128-42. PubMed ID: 27578179
[TBL] [Abstract][Full Text] [Related]
7. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
8. Dickkopf-1 (DKK1) promotes tumor growth via Akt-phosphorylation and independently of Wnt-axis in Barrett's associated esophageal adenocarcinoma.
Lyros O; Lamprecht AK; Nie L; Thieme R; Götzel K; Gasparri M; Haasler G; Rafiee P; Shaker R; Gockel I
Am J Cancer Res; 2019; 9(2):330-346. PubMed ID: 30906632
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of ErbB3 by Wnt3a contributes to wnt-induced osteoblast differentiation in mesenchymal cells.
Jullien N; Maudinet A; Leloutre B; Ringe J; Häupl T; Marie PJ
J Cell Biochem; 2012 Jun; 113(6):2047-56. PubMed ID: 22274864
[TBL] [Abstract][Full Text] [Related]
10. Expression and significance of Wnt signaling components and their target genes in breast carcinoma.
He Y; Liu Z; Qiao C; Xu M; Yu J; Li G
Mol Med Rep; 2014 Jan; 9(1):137-43. PubMed ID: 24190141
[TBL] [Abstract][Full Text] [Related]
11. Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus.
Clément G; Braunschweig R; Pasquier N; Bosman FT; Benhattar J
Oncogene; 2006 May; 25(21):3084-92. PubMed ID: 16407829
[TBL] [Abstract][Full Text] [Related]
12. DKK1 promotes migration and invasion of non-small cell lung cancer via β-catenin signaling pathway.
Zhang J; Zhang X; Zhao X; Jiang M; Gu M; Wang Z; Yue W
Tumour Biol; 2017 Jul; 39(7):1010428317703820. PubMed ID: 28677426
[TBL] [Abstract][Full Text] [Related]
13. Activation of Wnt signalling promotes development of dysplasia in Barrett's oesophagus.
Moyes LH; McEwan H; Radulescu S; Pawlikowski J; Lamm CG; Nixon C; Sansom OJ; Going JJ; Fullarton GM; Adams PD
J Pathol; 2012 Sep; 228(1):99-112. PubMed ID: 22653845
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
[TBL] [Abstract][Full Text] [Related]
15. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
Ma L; Wang X; Jia T; Wei W; Chua MS; So S
Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
[TBL] [Abstract][Full Text] [Related]
16. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
[TBL] [Abstract][Full Text] [Related]
17. Nmi (N-Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growth.
Fillmore RA; Mitra A; Xi Y; Ju J; Scammell J; Shevde LA; Samant RS
Int J Cancer; 2009 Aug; 125(3):556-64. PubMed ID: 19358268
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic postconditioning activates the Wnt/β-catenin pathway and protects against transient global cerebral ischemia through Dkk1 Inhibition and GSK-3β inactivation.
Zhan L; Liu D; Wen H; Hu J; Pang T; Sun W; Xu E
FASEB J; 2019 Aug; 33(8):9291-9307. PubMed ID: 31120770
[TBL] [Abstract][Full Text] [Related]
19. The effects of Dickkopf-4 on the proliferation, differentiation, and apoptosis of osteoblasts.
Hiramitsu S; Terauchi M; Kubota T
Endocrinology; 2013 Dec; 154(12):4618-26. PubMed ID: 24105477
[TBL] [Abstract][Full Text] [Related]
20. The role of the Wnt/β-catenin pathway in the effect of implant topography on MG63 differentiation.
Wang W; Zhao L; Ma Q; Wang Q; Chu PK; Zhang Y
Biomaterials; 2012 Nov; 33(32):7993-8002. PubMed ID: 22889483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
